The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients

Zhuravleva M.V.

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

Prokofiev A.B.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Private Dermatovenerologic Clinic, Svidnik, Slovak Republic;
Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation, Moscow, Russia

Arkhipov V.V.

Research center for examination of medical devices, Moscow, Russia

Serebrova S.Yu.

I.M. Sechenov First Moscow State Medical University, Ministry of Healthcare of the Russia, Moscow, Russia, 119991;
Scientific Center for Expertise of Medical Products, Ministry of Healthcare of the Russia, Moscow, Russia, 127051

Gorodetskaya G.I.

Demidova O.A.

Research center for examination of medical devices, Moscow, Russia

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(3): 92–96

The efficacy of ethylmethylhydroxypyridine in the rehabilitation treatment of poststroke patients

Authors:

Zhuravleva M.V., Prokofiev A.B., Arkhipov V.V., Serebrova S.Yu., Gorodetskaya G.I., Demidova O.A.

More about the authors

DOI: 10.17116/jnevro202012003192

Read: 5119 times

Open to cite this article

Close metadata

Recommended articles:

Comparison of the effectiveness of non-immunogenic staphylokinase and alteplase for intravenous thrombolysis in ischemic stroke: analysis of hospital registry data. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):139-144

Artificial ventilation in patients with stroke: main results of the Russian multicenter observational clinical trial RETAS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):5-13

The impact of the impairment of social cognitive functions in acute stage of stroke on its functional outcomes. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):21-25

Possibilities of mirror therapy in cognitive rehabilitation after stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):64-71

Post-stroke cognitive impairment in young patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):92-96

Rehabilitation of patients with facial neuropathy. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(2):28-41

Possibilities of using cytoprotectors in complex therapy of chronic coronary heart disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):410-419

Results of the impact of personalized rehabilitation on the quality of life of men after laparoscopic prostatectomy. P.A. Herzen Journal of Oncology. 2024;(4):22-28

Rehabilitation of patients after spinal surgery: effectiveness of nonthermal techniques of peloidotherapy. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(4):23-29

The role of mitochondrial dysfunction in the stabilization of the glaucomatous process. Russian Annals of Ophthalmology. 2024;(4):49-58

The analysis of the clinical efficacy and safety of ethylmethylhydroxypyridine succinate (mexidol) in the complex of rehabilitation measures in patients after ischemic stroke (IS) shows that course treatment with mexidol improves the recovery of neurological functions, decreases neurological deficit, cognitive disorders, including memory impairment, and manifestations of asthenic syndrome, increases the level of social adaptation and improves the psycho-emotional state of patients, reduces spasticity, increases motor and speech activity, praxis, reliably eliminates the ignoring syndrome. There is a decrease in the level of total cholesterol and low-density b-lipoproteins in the blood, and decrease in the severity of hypercoagulation. The results of the studies have convincingly shown the efficacy of mexidol at all stages of rehabilitation treatment of patients with IS.

Keywords:

ethylmethylhydroxypyridine succinate

Authors:

Zhuravleva M.V.

Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russia, Moscow, Russia

Prokofiev A.B.

Arkhipov V.V.

Research center for examination of medical devices, Moscow, Russia

Serebrova S.Yu.

Gorodetskaya G.I.

Demidova O.A.

Research center for examination of medical devices, Moscow, Russia

List of references:

Gusev EI, Martynov MYu, Kamchatnov PR. Ishemicheskij insul’t. Sovremennoe sostoyanie problemy. Doktor ru. 2013;5:83:7-12. (In Russ.).
Gusev EI, Skvorczova VI, Stakhovskaya LV. Epidemiology of stroke in Russia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Insul`t. 2003;8:4–9. (In Russ.).
Gusev EI, Skvorcova VI. Ishemiya golovnogo mozga. M: Medicina. 2001. (In Russ.).
Kamchatnov PR, Tyazhel`nikov AA, Osmaeva ZKh, Chugunov AV. Nejrometabolicheskie preparaty` v kompleksnoj terapii czerebrovaskulyarny`kh zabolevanij. Vrach. 2018;29(11):59–63. (In Russ.). https://doi.org/10.29296/25877305-2018-11-12
Karpikova NI, Peteryuhina AA. Primenenie preparata «Meksidol®» dlya lecheniya bol’nyh s zabolevaniyami sosudov golovnogo mozga. Byulleten’ eksperimental’noj biologii i mediciny. 2006;(supl 1):32-33. (In Russ.).
Kuznecova SM, Kuznecov VV, Yurchenko FV. Meksidol v reabilitacii bol’nyh pozhilogo vozrasta, perenesshih insul’t. Farmateka. 2009;15:105-108. (In Russ.).
Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases on the background of metabolic syndrome: new approaches to treatment. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2012;112(11):21-26. (In Russ.).
Abylaeva MT. Primenenie preparata meksidol v kompleksnom lechenii postinsul’tnyh rasstrojstv. Vestnik KAZNMU. 2012;2:37-38. (In Russ.).
Koval’chuk VV. Nejrometabolicheskaya terapiya kak sredstvo vtorichnoj profilaktiki insul’ta. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114(3):24-28. (In Russ.).
Koval’chuk VV. Effect of Mexidol on neurological deficits, social adaptation, and non-eclectic and «repulsive» syndromes in patients after stroke. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2011;12(2):52-57. (In Russ.).
Kuznecova EB, Salina EA, Sholomov II. Possibility of correction of cognitive disorders in the course of complex treatment of patients with the consequences of a brain infarction. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2015;115(11):103-106. (In Russ.).
Kuznecov VV, Yurchenko FV. Features of the effect of Mexidol on the functional state of the Central nervous system in patients who have suffered a stroke. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;6:18-20. (In Russ.).
Kispaeva TT. Preventive and therapeutic correction of the formation and progression of cognitive deficits in stroke patients. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2013;113(7):76-79. (In Russ.).
Koval’chuk VV, Skoromets AA. Vozmozhnosti Meksidola pri vosstanovlenii patsientov posle insul’ta. Medlajn-ehkspress. 2009;4-5(203):4-6. (In Russ.).